This is particularly relevant in the context of tumor MHC-I expression where MHC-I+ tumor cells elicit greater antigen-specific CD8+ T cell responses and MHC-I loss is a well-established mechanism of tumor immune evasion [39]. This evidence concerns the gene CD8A and neoplasm.